The global diabetic nephropathy market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period (2021-2027). As per CDC, diabetes is the major reason for end-stage renal disease (ESRD). Around 26 million people in the US had diabetes in 2011, and amongst them, more than 200,000 people had end-stage renal disease due to […]
